This page shows the latest Lanthio Pharma news and features for those working in and with pharma, biotech and healthcare.
Dr Axel Mescheder appointed CMO of MorphoSys subsidiary . Dutch biopharma firm Lanthio Pharma has appointed Dr Axel Mescheder as the new chief medical officer of its Lanthipeptide subsidiary MorphoSys. ... Axel's main focus will be the development of
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
No results were found
REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical education website. Support...